Basic Information
| RNALocate ID: | RLID:01000378 |
| RNA Symbol: | hsa-mir-149 |
| Localization: | Cytoplasm |
RNA Information
| RNA Name: | hsa-mir-149 |
| RNA ID: | miRBase:MI0000478 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 22058130 |
| Tissue/Cell Line: | HeLa cells |
| Method: | Next-generation RNA sequencing |
| Description: | Here, we present a data set excluding these RNA before sequencing through locked nucleic acids (LNA), greatly increasing pre-miRNA sequence counts with no discernable effect on pre-miRNA or mature miRNA sequencing. Analysis of profiles generated in total, nuclear and cytoplasmic cell fractions reveals that pre-miRNAs are subject to a wide range of regulatory processes involving loci-specific 3'- and 5'-end variation entailing complex cleavage patterns with co-occurring polyuridylation. Data were collected from Supplementary Table S2, S3. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01000379 | Nucleus | HeLa cells | 22058130 |
| RLID:11000157 | Exosome | Epidermal melanocytes (HEMa-LP)|Malignant melanoma cell line (A375) | 23056502 |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-mir-149 | Diffuse large b cell lymphoma | MNDR-E-MI-16200 |
| MNDR | hsa-mir-149 | Follicular lymphoma | MNDR-E-MI-16201 |
| MNDR | hsa-mir-149 | Medulloblastoma | MNDR-E-MI-16202 |
| MNDR | hsa-mir-149 | Non-hodgkin lymphoma somatic | MNDR-E-MI-16203 |
| MNDR | hsa-mir-149 | Anencephaly | MNDR-E-MI-16204 |
| MNDR | hsa-mir-149 | Colorectal carcinoma | MNDR-E-MI-16205 |
| MNDR | hsa-mir-149 | Melanoma and neural system tumor syndrome | MNDR-E-MI-16206 |
| MNDR | hsa-mir-149 | Dermatomyositis | MNDR-E-MI-16207 |
| MNDR | hsa-mir-149 | Prostate cancer | MNDR-E-MI-16208 |
| MNDR | hsa-mir-149 | Gastric cancer | MNDR-E-MI-16209 |
| MNDR | hsa-mir-149 | Alzheimer disease | MNDR-E-MI-16210 |
| MNDR | hsa-mir-149 | Sickle cell diseases | MNDR-E-MI-16211 |
| MNDR | hsa-mir-149 | Intracranial aneurysm | MNDR-E-MI-16212 |
| MNDR | hsa-mir-149 | Urinary bladder cancer | MNDR-E-MI-16213 |
| MNDR | hsa-mir-149 | Dysautonomia familial | MNDR-E-MI-16214 |
| MNDR | hsa-mir-149 | Leiomyoma | MNDR-E-MI-16215 |
| MNDR | hsa-mir-149 | Lung cancer | MNDR-E-MI-16216 |
| MNDR | hsa-mir-149 | Breast cancer | MNDR-E-MI-16217 |
| MNDR | hsa-mir-149 | Cancer | MNDR-E-MI-16218 |
| MNDR | hsa-mir-149 | Pituitary neoplasms | MNDR-E-MI-16219 |
| MNDR | hsa-mir-149 | Pancreatic cancer | MNDR-E-MI-16220 |
| MNDR | hsa-mir-149 | Hepatitis C | MNDR-E-MI-16221 |
| MNDR | hsa-mir-149 | Melanoma | MNDR-E-MI-16222 |
| MNDR | hsa-mir-149 | Williams syndrome | MNDR-E-MI-16223 |
| MNDR | hsa-mir-149 | Hepatitis b virus infection | MNDR-E-MI-16224 |
| MNDR | hsa-mir-149 | Multiple sclerosis relapsing-remitting | MNDR-E-MI-16225 |
| MNDR | hsa-mir-149 | Ovarian cancer | MNDR-E-MI-16226 |
| MNDR | hsa-mir-149 | Glioblastoma | MNDR-E-MI-16227 |
| MNDR | hsa-mir-149 | Glioblastoma multiforme somatic | MNDR-E-MI-16228 |
| MNDR | hsa-mir-149 | Astrocytoma | MNDR-E-MI-16229 |
| MNDR | hsa-mir-149 | Glioma | MNDR-E-MI-16230 |
| MNDR | hsa-mir-149 | Squamous cell neoplasm | MNDR-E-MI-16231 |
| MNDR | hsa-mir-149 | Oligodendroglioma | MNDR-E-MI-16232 |
| MNDR | hsa-mir-149 | Chordoma | MNDR-E-MI-16233 |
| MNDR | hsa-mir-149 | Amyotrophic lateral sclerosis | MNDR-E-MI-16234 |
| MNDR | hsa-mir-149 | Myositis inclusion body | MNDR-E-MI-16235 |
| MNDR | hsa-mir-149 | Infarction middle cerebral artery | MNDR-E-MI-16236 |
| MNDR | hsa-mir-149 | Acute cerebral infarction | MNDR-E-MI-16237 |
| MNDR | hsa-mir-149 | Pituitary adenoma | MNDR-E-MI-16238 |
| MNDR | hsa-mir-149 | Carcinoma lung non-small-cell | MNDR-E-MI-16239 |
| MNDR | hsa-mir-149 | Pancreatic adenocarcinoma | MNDR-E-MI-16240 |
| MNDR | hsa-mir-149 | Cervical cancer | MNDR-E-MI-16241 |
| MNDR | hsa-mir-149 | Myasthenia gravis autoimmune experimental | MNDR-E-MI-16242 |
| MNDR | hsa-mir-149 | Carcinoma renal cell | MNDR-E-MI-16243 |
| MNDR | hsa-mir-149 | Myelofibrosis idiopathic | MNDR-E-MI-16244 |
| MNDR | hsa-mir-149 | Esophageal cancer | MNDR-E-MI-16245 |
| MNDR | hsa-mir-149 | Head and neck squamous cell carcinoma | MNDR-E-MI-16246 |
| MNDR | hsa-mir-149 | Myocardial infarction | MNDR-E-MI-16247 |
| MNDR | hsa-mir-149 | Carcinoma hepatocellular | MNDR-E-MI-16248 |
| MNDR | hsa-mir-149 | Neuroblastoma | MNDR-E-MI-16249 |
| MNDR | hsa-mir-149 | Gastroesphageal reflux | MNDR-E-MI-16250 |
| MNDR | hsa-mir-149 | Leukemia acute myelogenous | MNDR-E-MI-16251 |
| MNDR | hsa-mir-149 | Colorectal cancer | MNDR-E-MI-16252 |
| MNDR | hsa-mir-149 | Nasopharyngeal carcinoma | MNDR-E-MI-16253 |
| MNDR | hsa-mir-149 | Nasopharynx carcinoma | MNDR-E-MI-16254 |
| MNDR | hsa-mir-149 | Multiple myeloma | MNDR-E-MI-16255 |
| MNDR | hsa-mir-149 | Uterine cervical neoplasms | MNDR-E-MI-16256 |
| MNDR | hsa-mir-149 | Ependymoma | MNDR-E-MI-16257 |
| MNDR | hsa-mir-149 | Cardiac hypertrophy | MNDR-E-MI-16258 |
| MNDR | hsa-mir-149 | Inflammation | MNDR-E-MI-16259 |
| MNDR | hsa-mir-149 | Prostatic neoplasms | MNDR-E-MI-16260 |
| MNDR | hsa-mir-149 | Subarachnoid hemorrhage traumatic | MNDR-E-MI-16261 |
| MNDR | hsa-mir-149 | Stroke lacunar | MNDR-E-MI-16262 |
| MNDR | hsa-mir-149 | Myocardial infarction susceptibility | MNDR-E-MI-16263 |
| MNDR | hsa-mir-149 | Stroke susceptibility | MNDR-E-MI-16264 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | hiv1-miR-H1 | Human immunodeficiency virus 1 | RR01625443 |
TOP